Why the study?
Does moxonidine effectively reduce blood pressure in patients with mild-to-moderate essential hypertension?
Does moxonidine effectively reduce blood pressure in patients with mild-to-moderate essential hypertension?
Moxonidine is an effective centrally acting antihypertensive that lowers blood pressure with minimal sedative side effects, and may offer additional metabolic benefits in obese hypertensive patients.
No takes yet. Share an insight, caveat, or question.
May offer alternative with fewer CNS effects amid rising Indian hypertension prevalence; leaves open confirmation in randomized trials.
Shetty et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: